« Back to Record
Fumagalli, D., Lambrechts, D., Neven, P., Vanderhaegen, J., Claes, B., Singhal, S., Piccart-Gebhart, M., Michiels, S., Sotiriou, C., & Loi, S. (2012). Molecular characterization of early-stage her2-overexpressing breast cancer (her2+ bc) treated with adjuvant trastuzumab: identification of prognostic groups. Annals of Oncology. Vol. 23 (Supplement 2) (p. ii21) Abstract session presented at IMPAKT Breast Cancer Conference 2012(May 3-5, 2012: Brussels, Belgium).
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/159009



